TransMedics Group (TMDX) Competitors $87.18 +0.34 (+0.39%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$85.65 -1.53 (-1.75%) As of 04/15/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TMDX vs. STVN, GKOS, NARI, INSP, BLCO, SLNO, IRTC, PRCT, NVST, and LIVNShould you be buying TransMedics Group stock or one of its competitors? The main competitors of TransMedics Group include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), PROCEPT BioRobotics (PRCT), Envista (NVST), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry. TransMedics Group vs. Stevanato Group Glaukos Inari Medical Inspire Medical Systems Bausch + Lomb Soleno Therapeutics iRhythm Technologies PROCEPT BioRobotics Envista LivaNova Stevanato Group (NYSE:STVN) and TransMedics Group (NASDAQ:TMDX) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, community ranking, earnings, profitability, valuation, dividends and institutional ownership. Do analysts recommend STVN or TMDX? TransMedics Group has a consensus target price of $122.70, suggesting a potential upside of 40.74%. Given TransMedics Group's stronger consensus rating and higher possible upside, analysts plainly believe TransMedics Group is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71TransMedics Group 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.82 Which has more risk & volatility, STVN or TMDX? Stevanato Group has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.14, indicating that its stock price is 114% more volatile than the S&P 500. Is STVN or TMDX more profitable? Stevanato Group has a net margin of 10.47% compared to TransMedics Group's net margin of 8.14%. TransMedics Group's return on equity of 18.74% beat Stevanato Group's return on equity.Company Net Margins Return on Equity Return on Assets Stevanato Group10.47% 9.86% 5.79% TransMedics Group 8.14%18.74%4.39% Does the MarketBeat Community prefer STVN or TMDX? TransMedics Group received 82 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 62.50% of users gave Stevanato Group an outperform vote while only 58.95% of users gave TransMedics Group an outperform vote. CompanyUnderperformOutperformStevanato GroupOutperform Votes3062.50% Underperform Votes1837.50% TransMedics GroupOutperform Votes11258.95% Underperform Votes7841.05% Which has better valuation and earnings, STVN or TMDX? Stevanato Group has higher revenue and earnings than TransMedics Group. Stevanato Group is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStevanato Group$1.10B6.18$157.62M$0.4846.96TransMedics Group$441.54M6.65-$25.03M$1.0186.32 Do insiders and institutionals hold more shares of STVN or TMDX? 99.7% of TransMedics Group shares are held by institutional investors. 0.7% of Stevanato Group shares are held by company insiders. Comparatively, 7.0% of TransMedics Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media prefer STVN or TMDX? In the previous week, TransMedics Group had 39 more articles in the media than Stevanato Group. MarketBeat recorded 44 mentions for TransMedics Group and 5 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 1.22 beat TransMedics Group's score of 0.17 indicating that Stevanato Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TransMedics Group 10 Very Positive mention(s) 6 Positive mention(s) 24 Neutral mention(s) 0 Negative mention(s) 3 Very Negative mention(s) Neutral SummaryTransMedics Group beats Stevanato Group on 13 of the 19 factors compared between the two stocks. Remove Ads Get TransMedics Group News Delivered to You Automatically Sign up to receive the latest news and ratings for TMDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMDX vs. The Competition Export to ExcelMetricTransMedics GroupElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.93B$3.09B$5.33B$7.57BDividend YieldN/A1.81%5.11%4.32%P/E Ratio92.7514.3421.7317.81Price / Sales6.6543.73379.2094.61Price / Cash530.0844.0938.1534.64Price / Book20.763.336.464.00Net Income-$25.03M$94.03M$3.20B$247.23M7 Day Performance28.30%5.33%6.54%7.26%1 Month Performance27.21%-8.47%-8.55%-6.26%1 Year Performance-5.05%-22.20%10.33%-0.18% TransMedics Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMDXTransMedics Group2.7688 of 5 stars$87.18+0.4%$122.70+40.7%-5.1%$2.93B$441.54M92.75210STVNStevanato Group1.7406 of 5 stars€19.07+0.3%N/A-23.5%$5.78B$1.10B40.574,650Positive NewsGap DownGKOSGlaukos4.5608 of 5 stars$87.32+4.4%$163.25+87.0%-2.4%$4.90B$383.48M-30.20780Analyst ForecastHigh Trading VolumeNARIInari Medical0.3536 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800INSPInspire Medical Systems4.6381 of 5 stars$151.78+6.9%$226.70+49.4%-34.3%$4.49B$802.80M87.171,246Analyst ForecastNews CoveragePositive NewsGap UpBLCOBausch + Lomb3.8719 of 5 stars$11.73-3.1%$18.82+60.4%-16.5%$4.12B$4.79B-12.8512,500Gap DownSLNOSoleno Therapeutics4.7804 of 5 stars$68.63+1.7%$99.63+45.2%+82.4%$3.13BN/A-20.5830Analyst ForecastGap DownIRTCiRhythm Technologies0.9177 of 5 stars$100.46+0.1%$119.73+19.2%-8.0%$3.12B$591.84M-27.291,790Positive NewsPRCTPROCEPT BioRobotics2.3993 of 5 stars$51.67+0.9%$94.29+82.5%+4.6%$2.80B$224.50M-26.15430Positive NewsGap DownNVSTEnvista4.3811 of 5 stars$15.30-1.1%$20.18+31.9%-21.0%$2.63B$2.51B-2.3512,700Analyst ForecastAnalyst RevisionNews CoveragePositive NewsGap DownLIVNLivaNova3.555 of 5 stars$35.61-0.9%$61.17+71.7%-34.8%$1.93B$1.25B84.482,900News CoveragePositive NewsGap Down Remove Ads Related Companies and Tools Related Companies Stevanato Group Alternatives Glaukos Alternatives Inari Medical Alternatives Inspire Medical Systems Alternatives Bausch + Lomb Alternatives Soleno Therapeutics Alternatives iRhythm Technologies Alternatives PROCEPT BioRobotics Alternatives Envista Alternatives LivaNova Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TMDX) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransMedics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransMedics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TMDX Stock Free TMDX Stock Alerts